A Study to Evaluate the Glucagon and Incretin Responses and Identify the Role of Extrapancreatic Glucagon in Patients with Fibrocalcific Pancreatic Diabetes

被引：0
|
作者：
Shankar, Anand
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-224-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
224-LB
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients
    Skelin, Marko
    Javor, Eugen
    Lucijanic, Marko
    Lucijanic, Tomo
    Jakupovic, Lejsa
    Rahelic, Dario
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2018, 72 (12)
  • [22] Response to 'The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes'
    Bertero, Edoardo
    Sequeira, Vasco
    Heymans, Stephane
    Maack, Christoph
    EUROPEAN HEART JOURNAL, 2020, 41 (02) : 326 - 327
  • [23] Possible role of alpha cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes
    Shimizu, A.
    Tsuchiyama, N.
    Ando, H.
    Kato, K.-I.
    Kurita, S.
    Sakurai, M.
    Kaneko, S.
    Takamura, T.
    DIABETOLOGIA, 2007, 50 : S318 - S318
  • [24] Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus
    Kolb, Armin
    Rieder, Simon
    Born, Diana
    Giese, Nathalia A.
    Giese, Thomas
    Rudofsky, Gottfried
    Werner, Jens
    Buechler, Markus W.
    Friess, Helmut
    Esposito, Irene
    Kleeff, Joerg
    CANCER BIOLOGY & THERAPY, 2009, 8 (16) : 1527 - 1533
  • [25] DOES GLUCAGON PLAY A ROLE IN INSULIN RESISTANCE OF PATIENTS WITH ADULT NON-KETOTIC DIABETES
    OLEFSKY, JM
    SPERLING, MA
    REAVEN, GM
    DIABETOLOGIA, 1977, 13 (04) : 327 - 330
  • [26] PROSPECTIVE-STUDY OF GLUCOSE-TOLERANCE, INSULIN, C-PEPTIDE, AND GLUCAGON-RESPONSES IN PATIENTS WITH PANCREATIC-CARCINOMA
    SCHWARTZ, SS
    ZEIDLER, A
    MOOSSA, AR
    KUKU, SF
    RUBENSTEIN, AH
    AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1978, 23 (12): : 1107 - 1114
  • [27] Glucagon-Like Peptide 1-Based Therapies and Risk of Pancreatic Cancer in Patients With Diabetes and Obesity
    Krishnan, Arunkumar
    Hadi, Yousaf
    Hutson, William R.
    Thakkar, Shyam
    Singh, Shailendra
    PANCREAS, 2022, 51 (10) : 1398 - 1403
  • [28] Effect of oral glibenclamide on the glucagon and adrenaline responses to hypoglycemia in insulin-treated patients with type 2 diabetes
    Landstedt-Hallin, L
    Adamson, U
    Lins, PE
    DIABETES, 1998, 47 : A37 - A37
  • [29] Comparison of Glucagon Values of healthy Study Participants and Patients with Diabetes Mellitus by means of ELISA and RIA
    Brunner, Martina
    Haberlander, Maximilian
    Svehlikova, Eva
    Lipp, Robert
    Stach, Lisa
    Obermayer-Pietsch, Barbara
    Pieber, Thomas Rudolf
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 178 - 179
  • [30] MEDI0382, a glucagon-like peptide/glucagon receptor dual agonist, in patients with type 2 diabetes: a multiple-ascending-dose study
    Robertson, D.
    Stumvoll, M.
    Posch, M.
    Heise, T.
    Plum-Moerschel, L.
    Klein, G.
    Tsai, L. -F.
    Petrone, M.
    Hirshberg, B.
    Rondinone, C.
    Parker, V.
    Jermutus, L.
    Ambery, P.
    DIABETOLOGIA, 2018, 61 : S348 - S348
12345